Literature DB >> 9691091

Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors.

J P Iredale1, R C Benyon, J Pickering, M McCullen, M Northrop, S Pawley, C Hovell, M J Arthur.   

Abstract

Liver fibrosis results from the excessive secretion of matrix proteins by hepatic stellate cells (HSC), which proliferate during fibrotic liver injury. We have studied a model of spontaneous recovery from liver fibrosis to determine the biological mechanisms mediating resolution. Livers were harvested from rats at 0, 3, 7, and 28 d of spontaneous recovery from liver fibrosis induced by 4 wk of twice weekly intraperitoneal injections with CCl4. Hydroxyproline analysis and histology of liver sections indicated that the advanced septal fibrosis observed at time 0 (peak fibrosis) was remodeled over 28 d of recovery to levels close to control (untreated liver). alpha-Smooth muscle actin staining of liver sections demonstrated a 12-fold reduction in the number of activated HSC over the same time period with evidence of HSC apoptosis. Ribonuclease protection analysis of liver RNA extracted at each recovery time point demonstrated a rapid decrease in expression of the collagenase inhibitors TIMP-1 and TIMP-2, whereas collagenase mRNA expression remained at levels comparable to peak fibrosis. Collagenase activity in liver homogenates increased through recovery. We suggest that apoptosis of activated HSC may vitally contribute to resolution of fibrosis by acting as a mechanism for removing the cell population responsible for both producing fibrotic neomatrix and protecting this matrix from degradation via their production of TIMPs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9691091      PMCID: PMC508915          DOI: 10.1172/JCI1018

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

Review 1.  Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies.

Authors:  S L Friedman
Journal:  N Engl J Med       Date:  1993-06-24       Impact factor: 91.245

2.  Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver.

Authors:  J P Iredale; G Murphy; R M Hembry; S L Friedman; M J Arthur
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

3.  Serum tissue inhibitor of metalloproteinases in patients with chronic liver disease and with hepatocellular carcinoma.

Authors:  Y Murawaki; H Yamamoto; H Kawasaki; H Shima
Journal:  Clin Chim Acta       Date:  1993-09-17       Impact factor: 3.786

4.  Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis.

Authors:  A J Baker; A Mooney; J Hughes; D Lombardi; R J Johnson; J Savill
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

5.  Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas.

Authors:  J M Freije; I Díez-Itza; M Balbín; L M Sánchez; R Blasco; J Tolivia; C López-Otín
Journal:  J Biol Chem       Date:  1994-06-17       Impact factor: 5.157

6.  Clinical evaluation of serum tissue inhibitor of metalloproteinases-1 levels in patients with liver diseases.

Authors:  D A Muzzillo; M Imoto; Y Fukuda; Y Koyama; S Saga; Y Nagai; T Hayakawa
Journal:  J Gastroenterol Hepatol       Date:  1993 Sep-Oct       Impact factor: 4.029

7.  Serum collagenase activity in chronic liver diseases.

Authors:  Y Murawaki; H Kawasaki; H Burkhardt
Journal:  Pathol Res Pract       Date:  1994-10       Impact factor: 3.250

8.  Cooperative interaction between c-myc and bcl-2 proto-oncogenes.

Authors:  A Fanidi; E A Harrington; G I Evan
Journal:  Nature       Date:  1992-10-08       Impact factor: 49.962

9.  Polyunsaturated lecithin prevents acetaldehyde-mediated hepatic collagen accumulation by stimulating collagenase activity in cultured lipocytes.

Authors:  J Li; C I Kim; M A Leo; K M Mak; M Rojkind; C S Lieber
Journal:  Hepatology       Date:  1992-03       Impact factor: 17.425

Review 10.  C. L. Oakley Lecture (1993). Cellular and molecular aspects of hepatic fibrosis.

Authors:  A D Burt
Journal:  J Pathol       Date:  1993-06       Impact factor: 7.996

View more
  288 in total

Review 1.  Is liver fibrosis reversible?

Authors:  R C Benyon; J P Iredale
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

2.  Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 expression in fibrotic rat liver.

Authors:  Hai-Lin Liu; Xuan-Hai Li; Dan-Yi Wang; Shao-Ping Yang
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

3.  Regulation of E-box DNA binding during in vivo and in vitro activation of rat and human hepatic stellate cells.

Authors:  K J Vincent; E Jones; M J Arthur; D E Smart; J Trim; M C Wright; D A Mann
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

4.  Effects of Yigan Decoction on proliferation and apoptosis of hepatic stellate cells.

Authors:  Xi-Xian Yao; You-Wei Tang; Dong-Mei Yao; He-Ming Xiu
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

5.  Salvia miltiorrhiza monomer IH764-3 induces hepatic stellate cell apoptosis via caspase-3 activation.

Authors:  Xiao-Lan Zhang; Li Liu; Hui-Qing Jiang
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

6.  Holeuryhalinity and its mechanisms in a cirriped crustacean, Balanus improvisus.

Authors:  H J Fyhn
Journal:  Comp Biochem Physiol A Comp Physiol       Date:  1976-01

7.  Mouse models of liver fibrosis mimic human liver fibrosis of different etiologies.

Authors:  Allyson K Martínez; Luca Maroni; Marco Marzioni; Syed T Ahmed; Mena Milad; Debolina Ray; Gianfranco Alpini; Shannon S Glaser
Journal:  Curr Pathobiol Rep       Date:  2014-12-01

8.  Gut homing receptors on CD8 T cells are retinoic acid dependent and not maintained by liver dendritic or stellate cells.

Authors:  Bertus Eksteen; J Rodrigo Mora; Emma L Haughton; Neil C Henderson; Laura Lee-Turner; Eduardo J Villablanca; Stuart M Curbishley; Alex I Aspinall; Ulrich H von Andrian; David H Adams
Journal:  Gastroenterology       Date:  2009-02-21       Impact factor: 22.682

9.  Nuclear factor-kappaB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury.

Authors:  Fiona Oakley; Jelena Mann; Sarah Nailard; David E Smart; Narendra Mungalsingh; Christothea Constandinou; Shakir Ali; Susan J Wilson; Harry Millward-Sadler; John P Iredale; Derek A Mann
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

10.  Deficiency of nicotinamide adenine dinucleotide phosphate, reduced form oxidase enhances hepatocellular injury but attenuates fibrosis after chronic carbon tetrachloride administration.

Authors:  Ghazaleh Aram; James J Potter; Xiaopu Liu; Lan Wang; Michael S Torbenson; Esteban Mezey
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.